These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9035017)

  • 1. Etodolac (Lodine) in the treatment of osteoarthritis: recent studies.
    Schnitzer TJ; Constantine G
    J Rheumatol Suppl; 1997 Feb; 47():23-31. PubMed ID: 9035017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
    Fleischmann RM; Flint K; Constantine G; Kolecki B
    Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis.
    Krug H; Broadwell LK; Berry M; DeLapp R; Palmer RH; Mahowald M
    Clin Ther; 2000 Jan; 22(1):40-52. PubMed ID: 10688389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of naproxen CR and nabumetone in the treatment of patients with osteoarthritis of the knee.
    Cha HS; Koh JH; Jeon CH; Lee CK; Kim JS; Koh EM
    Int J Clin Pharmacol Ther; 2001 Dec; 39(12):539-45. PubMed ID: 11770835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.
    Dore R; Ballard I; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):656-66. PubMed ID: 8565029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longterm endoscopic evaluation of patients with arthritis treated with nabumetone vs naproxen.
    Roth SH; Bennett R; Caldron P; Mitchell C; Swenson C; Koepp R
    J Rheumatol; 1994 Jun; 21(6):1118-23. PubMed ID: 7932425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.
    Pisko EJ; Strader K; Rice D; White R; Goodman LA
    Pharmatherapeutica; 1987; 5(2):90-8. PubMed ID: 3310020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
    D'Hooghe M
    Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Bacon P
    Rheumatol Int; 1993; 13(2 Suppl):S7-12. PubMed ID: 8210924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.
    Neustadt DH
    J Rheumatol Suppl; 1997 Feb; 47():17-22. PubMed ID: 9035016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis.
    Dreiser RL
    Rheumatol Int; 1993; 13(2 Suppl):S13-8. PubMed ID: 8210919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
    Schnitzer TJ; Kamin M; Olson WH
    Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis.
    Pisko EJ; Bockow BI; Box P; Brodsky AL; Burch FX; Collins RL; Fleischmann RM; Keller MI; Lipani JA; Poiley JE
    Am J Med; 1987 Oct; 83(4B):86-91. PubMed ID: 3318436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.